Invivyd Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.59

-0.05 (-7.51%)

As of Nov 7, 2:04 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +3,565.5% upside

Low Target $15.01

Average Target $21.48

High Target $34.49

Current Price $0.59

Current
$0.59

Target
$21.48

$15.01 $21.48 avg $34.49

Scenario Analysis

Bear Case

$15.01

2,461.4%

Low target

Base Case

$21.48

+3,565.5%

Avg target

Bull Case

$34.49

+5,785.7%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$3.07

-80.9% from high

52-Week Low

$0.53

+11.0% from low

Target vs 52W High

$21.48

+599.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%